Cite

HARVARD Citation

    Xue, C. et al. (2022). LncRNA CDKN2B-AS1 Could Be an Indicator to Identify Prognosis and Status of Immune Microenvironment in Thyroid Cancer. Disease markers. p. . [Online]. 
  
Back to record